Author:
Burnett Allison E.,Mahan Charles E.,Vazquez Sara R.,Oertel Lynn B.,Garcia David A.,Ansell Jack
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Reference139 articles.
1. Van der Hulle T, Kooiman J, den Exter PL et al (2014) Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 12:320–328. doi: 10.1111/jth.12485
2. Mantha S, Ansell J (2014) Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism. J Thromb Thrombolysis. doi: 10.1007/s11239-014-1102-5
3. Schulman S, Kearon C, Kakkar AK et al (2013) Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med 368:709–718. doi: 10.1056/NEJMoa1113697
4. EINSTEIN Investigators, Bauersachs R, Berkowitz SD et al (2010) Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 363:2499–2510. doi: 10.1056/NEJMoa1007903
5. Agnelli G, Buller HR, Cohen A et al (2013) Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368:699–708. doi: 10.1056/NEJMoa1207541
Cited by
287 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献